3.145.12.181
dgid:
enl:
npi:0
-Advertisement-
Home Impact of Newer Prostaglandin Analogs on Treatment of Glaucoma

Glaucoma

Impact of Newer Prostaglandin Analogs on Treatment of Glaucoma

Read More
By rd360stg
Comparative study highlights iStent superiority over ECP in glaucoma treatment
By rd360stg
Demographic factors influence uptake of glaucoma screening in first-degree relatives following a familial diagnosis
By rd360stg
Roundtable Review: Which glaucoma treatment does Dr. David Stephens usually start with?
By rd360stg
Medication-First Approach for Glaucoma
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Clustered testing approach may identify fast-progressing glaucoma
By rd360stg
Microsoft, Topcon announce partnership on AI-based eye scan
By rd360stg
Demographic, ocular factors relevant to RNFL measurements in patients with glaucoma
By rd360stg
Higher BMI appears to be protective against glaucoma progression
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Unmet Needs of Standalone Glaucoma Surgery
By rd360stg
Decade-long study shows iStent’s enduring efficacy in glaucoma treatment
By rd360stg
New trabecular MIGS device shows promise in treating glaucoma
By rd360stg
Streamline Surgical System Showcased at AGS Meeting
-Advertisement-
-Advertisement-
Videos
All
Impact of Newer Prostaglandin Analogs on Treatment of Glaucoma
18 Jun, 2024

Nathan M. Radcliffe, Shan Lin, and Arkadiy Yadgarov explore how...

Medication-First Approach for Glaucoma
25 May, 2024
Quizzes
All
Roundtable Review: Which glaucoma treatment does Dr. David Stephens usually start with?
29 May, 2024

-Advertisement-
-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899
[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-
-Advertisement-